TY - JOUR
T1 - Electroencephalography at the height of a pandemic
T2 - EEG findings in patients with COVID-19
AU - Tantillo, Gabriela B.
AU - Jetté, Nathalie
AU - Gururangan, Kapil
AU - Agarwal, Parul
AU - Marcuse, Lara
AU - Singh, Anuradha
AU - Goldstein, Jonathan
AU - Kwon, Churl Su
AU - Dhamoon, Mandip S.
AU - Navis, Allison
AU - Nadkarni, Girish N.
AU - Charney, Alexander W.
AU - Young, James J.
AU - Blank, Leah J.
AU - Fields, Madeline
AU - Yoo, Ji Yeoun
N1 - Funding Information:
The authors acknowledge the members of the Mount Sinai Department of Neurology, including our EEG technologists, residents, fellows, and staff for their service on the front lines of the COVID-19 pandemic. N. Jette is the Bludhorn Professor of International Medicine at the Icahn School of Medicine at Mount Sinai. None. G.B. Tantillo previously held shares in a diversified healthcare index exchange traded fund unrelated to this work. N. Jetté receives grant funding paid to her institution for grants unrelated to this work from NINDS (NIH U24NS107201, NIH IU54NS100064) and PCORI. She receives an honorarium for her work as an Associate Editor of Epilepsia. K. Gururangan is a scientific advisor and consultant to Ceribell and owns stock options in Ceribell. P. Agarwal reports no disclosures relevant to the manuscript. L.V. Marcuse receives royalties from the book “Primer of EEG”. A. Singh has received royalties from the book “Neurology Image-Based Clinical Review”. J. Goldstein reports no disclosures relevant to the manuscript. C.S. Kwon is a holder of a Leon Levy Fellowship. M. Dhamoon reports no disclosures relevant to the manuscript. M.C. Fields receives royalties from the book “Primer of EEG”. A. Navis is a recipient of the NIH LRP. G.N. Nadkarni reports no disclosures relevant to the manuscript. A.W. Charney reports no disclosures relevant to the manuscript. J.J. Young receives research support from Monteris (for unrelated research) as well as grant support from NINDS R25 (NS8440304) and the Leon Levy Foundation. L.J. Blank reports no disclosures relevant to the manuscript. J.Y. Yoo receives royalties from Elsevier from the book “Primer of EEG” and serves as a consultant to Zimmer Biomet and LVIS corporation. Gabriela B. Tantillo (corresponding author, guarantor): study conceptualization, data collection, statistical analysis, drafted the manuscript, reviewed the manuscript. Nathalie Jetté (author): study conceptualization, data collection, statistical analysis, reviewed the manuscript. Kapil Gururangan (author): drafted and reviewed the manuscript. Parul Agarwal (author): statistical analysis (primary), reviewed the manuscript. Lara V. Marcuse (author): study conceptualization, data collection, reviewed the manuscript. Anuradha Singh (author): study conceptualization, data collection, reviewed the manuscript. Jonathan Goldstein (author): data collection, reviewed the manuscript. Churl-Su Kwon (author): data collection, reviewed the manuscript. Mandip Dhamoon (author): data collection, reviewed the manuscript. Madeline C. Fields (author): data collection, reviewed the manuscript. Allison Navis (author): study conceptualization, reviewed the manuscript. Girish N. Nadkarni (author): reviewed the manuscript. Alexander W. Charney (author): reviewed the manuscript. James J. Young (author): reviewed the manuscript. Leah J. Blank (author): reviewed the manuscript. Ji Yeoun Yoo (senior author): study conceptualization, data collection, statistical analysis, reviewed the manuscript.
Funding Information:
G.B. Tantillo previously held shares in a diversified healthcare index exchange traded fund unrelated to this work. N. Jetté receives grant funding paid to her institution for grants unrelated to this work from NINDS (NIH U24NS107201, NIH IU54NS100064) and PCORI. She receives an honorarium for her work as an Associate Editor of Epilepsia. K. Gururangan is a scientific advisor and consultant to Ceribell and owns stock options in Ceribell. P. Agarwal reports no disclosures relevant to the manuscript. L.V. Marcuse receives royalties from the book “Primer of EEG”. A. Singh has received royalties from the book “Neurology Image-Based Clinical Review”. J. Goldstein reports no disclosures relevant to the manuscript. C.S. Kwon is a holder of a Leon Levy Fellowship. M. Dhamoon reports no disclosures relevant to the manuscript. M.C. Fields receives royalties from the book “Primer of EEG”. A. Navis is a recipient of the NIH LRP. G.N. Nadkarni reports no disclosures relevant to the manuscript. A.W. Charney reports no disclosures relevant to the manuscript. J.J. Young receives research support from Monteris (for unrelated research) as well as grant support from NINDS R25 (NS8440304) and the Leon Levy Foundation. L.J. Blank reports no disclosures relevant to the manuscript. J.Y. Yoo receives royalties from Elsevier from the book “Primer of EEG” and serves as a consultant to Zimmer Biomet and LVIS corporation.
Publisher Copyright:
© 2022 International Federation of Clinical Neurophysiology
PY - 2022/5
Y1 - 2022/5
N2 - Objective: To characterize continuous video electroencephalogram (VEEG) findings of hospitalized COVID-19 patients. Methods: We performed a retrospective chart review of patients admitted at three New York City hospitals who underwent VEEG at the peak of the COVID-19 pandemic. Demographics, comorbidities, neuroimaging, VEEG indications and findings, treatment, and outcomes were collected. Results: Of 93 patients monitored, 77% had severe COVID-19 and 40% died. Acute ischemic or hemorrhagic stroke was present in 26% and 15%, respectively. Most common VEEG indications were encephalopathy/coma (60%) and seizure-like movements (38%). Most common VEEG findings were generalized slowing (97%), generalized attenuation (31%), generalized periodic discharges (17%) and generalized sharp waves (15%). Epileptiform abnormalities were present in 43% and seizures in 8% of patients, all of whom had seizure risk factors. Factors associated with an epileptiform VEEG included increasing age (OR 1.07, p = 0.001) and hepatic/renal failure (OR 2.99, p = 0.03). Conclusions: Most COVID-19 patients who underwent VEEG monitoring had severe COVID-19 and over one-third had acute cerebral injury (e.g., stroke, anoxia). Seizures were uncommon. VEEG findings were nonspecific. Significance: VEEG findings in this cohort of hospitalized COVID-19 patients were those often seen in critical illness. Seizures were uncommon and occurred in the setting of common seizure risk factors.
AB - Objective: To characterize continuous video electroencephalogram (VEEG) findings of hospitalized COVID-19 patients. Methods: We performed a retrospective chart review of patients admitted at three New York City hospitals who underwent VEEG at the peak of the COVID-19 pandemic. Demographics, comorbidities, neuroimaging, VEEG indications and findings, treatment, and outcomes were collected. Results: Of 93 patients monitored, 77% had severe COVID-19 and 40% died. Acute ischemic or hemorrhagic stroke was present in 26% and 15%, respectively. Most common VEEG indications were encephalopathy/coma (60%) and seizure-like movements (38%). Most common VEEG findings were generalized slowing (97%), generalized attenuation (31%), generalized periodic discharges (17%) and generalized sharp waves (15%). Epileptiform abnormalities were present in 43% and seizures in 8% of patients, all of whom had seizure risk factors. Factors associated with an epileptiform VEEG included increasing age (OR 1.07, p = 0.001) and hepatic/renal failure (OR 2.99, p = 0.03). Conclusions: Most COVID-19 patients who underwent VEEG monitoring had severe COVID-19 and over one-third had acute cerebral injury (e.g., stroke, anoxia). Seizures were uncommon. VEEG findings were nonspecific. Significance: VEEG findings in this cohort of hospitalized COVID-19 patients were those often seen in critical illness. Seizures were uncommon and occurred in the setting of common seizure risk factors.
KW - COVID-19
KW - EEG
KW - Electroencephalography
KW - Seizures
KW - neuroCOVID
UR - http://www.scopus.com/inward/record.url?scp=85126374220&partnerID=8YFLogxK
U2 - 10.1016/j.clinph.2022.03.001
DO - 10.1016/j.clinph.2022.03.001
M3 - Article
C2 - 35305494
AN - SCOPUS:85126374220
VL - 137
SP - 102
EP - 112
JO - Clinical Neurophysiology
JF - Clinical Neurophysiology
SN - 1388-2457
ER -